China last week announced it was done retaliating against U.S. President Donald Trump’s tariffs, saying any further increases ...

Beijing has wielded a wide range of punitive measures in recent days to strike back at Washington, including steps targeting ...

The White House said Tuesday that "the ball is in China's court," as far as a trade deal with the U.S. is concerned.

BofA lowered the firm’s price target on Illumina (ILMN) to $75 from $90 and keeps an Underperform rating on the shares. Sentiment for Life ...

The White House said Tuesday that "the ball is in China's court," as far as a trade deal with the U.S. is concerned.

Illumina has been caught in the middle of a tariff war between the U.S. and China that has compelled it to cut its annual forecast and implement a cost-savings plan. China, which accounts for 7% ...

Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today responded to the March 4, 2025 notice from the China Ministry of Commerce ("MOFCOM") that Illumina is not permitted to export ...

Swiss pharmaceutical giant Novartis announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corporation (BAC), ...

China has launched a sweeping and strategic retaliation against the US in response to long-standing Trump-era tariffs, with measures ranging from harsh new tariffs on US goods to targeted strikes ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0555 ET – A U.S. investigation into pharmaceutical imports and ...

China to block Chinese firms from investing in the U.S. amid tariff war; Shenzhen launches incentives for foreign-owned ...